ClinicalTrials.Veeva

Menu
A

Alea Research | Phoenix, AZ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rapastinel
KarXT
Pilocarpine
Balovaptan
Troriluzule
Troriluzole
BI 409306
Atogepant
Liafensine
Dihydroergotamine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 18 total trials

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

This is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive...

Enrolling
Schizophrenia
Drug: Xanomeline and Trospium Chloride Capsules

The study's purpose its to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compu...

Active, not recruiting
Obsessive-Compulsive Disorder
Drug: Troriluzole
Drug: Placebo

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only
Obsessive Compulsive Disorder
Drug: Troriluzole (BHV-4157)

Trial sponsors

AbbVie logo
Allergan logo
Biohaven logo
Karuna Therapeutics logo
Allergan logo
Boehringer Ingelheim logo
D
E
G
Ocuphire Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems